Approval · Notice of Compliance 12669 · 2011
IBUPROFEN: Notice of Compliance 12669
Issued September 29, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12669
- Date
- September 29, 2011
- Company
- Pharmascience Inc.Montreal, Quebec, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Manufacturer Name Change
- Therapeutic class
- Non-steroidal Anti-inflammatory Drug / Analgesic / Antipyretic Agent
- Canadian reference product
- MOTRIN (Mcneil Consumer Healthcare)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| IBUPROFEN | 02314754 | Marketed |
| EXTRA STRENGTH IBUPROFEN | 02314770 | Marketed |
| IBUPROFEN (CAPLET) | 02314762 | Marketed |